DSF Clinical Research Grants

Clinical Research Grants support hypothesis-driven clinical research projects that have significant potential to advance our understanding of Dravet syndrome; slow or halt the of progression of the disease, characteristics, or comorbidities of the disease; and/or reduce mortality. This also includes studies that help identify patient trends, characteristics, epidemiology, or other clinical aspects of Dravet syndrome. This research will be patient-oriented research in which an investigator directly interacts with human subjects/patients. Such studies may be conducted in conjunction with laboratory-based research, as appropriate. This includes studies such as therapeutic interventions or clinical trials.

Award funds of $250,000 distributed over two years are made to the affiliated institution in four payments, the second of which is dependent on IRB approval if not required for the first portion of the funding period. Indirect costs may not exceed 10% of the total award and must be included in the $250,000 budget.

Successful applicants hold an MD, PhD, DO or equivalent degree. Applicants should be well-established independent investigators affiliated with an academic or research institution (excluding for-profit companies). Applicants within the US and foreign countries are eligible.

Investigators applying for a clinical research grant should ensure their proposed project addresses the needs of the Dravet syndrome community and DSF’s mission to support research toward better treatments and a cure for Dravet syndrome.

Tags: Dravet Syndrome, SCN1A, Clinical Epilepsy, Human Studies, Devices, Technologies, Stem Cells, Biomarkers, Behavior, Neuropsychology, Language, Genetics, Epidemiology, Epilepsy Care Professionals, Comorbidity (Somatic and Psychiatric), Antiepileptic Drugs, Non-AED, Non-Surgical Treatments , SUDEP